CN111285774A - Asymmetric imine hydrogenation method based on chiral monodentate phosphine ligand derived from D-mannitol - Google Patents

Asymmetric imine hydrogenation method based on chiral monodentate phosphine ligand derived from D-mannitol Download PDF

Info

Publication number
CN111285774A
CN111285774A CN201811500419.8A CN201811500419A CN111285774A CN 111285774 A CN111285774 A CN 111285774A CN 201811500419 A CN201811500419 A CN 201811500419A CN 111285774 A CN111285774 A CN 111285774A
Authority
CN
China
Prior art keywords
chiral
mannitol
phosphine ligand
imine
monodentate phosphine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811500419.8A
Other languages
Chinese (zh)
Inventor
胡向平
胡信虎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Institute of Chemical Physics of CAS
Original Assignee
Dalian Institute of Chemical Physics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Institute of Chemical Physics of CAS filed Critical Dalian Institute of Chemical Physics of CAS
Priority to CN201811500419.8A priority Critical patent/CN111285774A/en
Publication of CN111285774A publication Critical patent/CN111285774A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/44Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers
    • C07C209/52Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers by reduction of imines or imino-ethers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60Reduction reactions, e.g. hydrogenation
    • B01J2231/64Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82Metals of the platinum group
    • B01J2531/827Iridium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a method for asymmetrically hydrogenating imine based on a chiral monodentate phosphine ligand derived from D-mannitol, which comprises the following steps: chiral monodentate phosphine ligand derived from D-mannitol reacts with metal iridium precursor to prepare complex in situ as catalyst, and imine is asymmetrically hydrogenated to prepare chiral amine. Suitable amounts of catalyst (in moles) are: the starting imine/catalyst (S/C) is equal to 100-10000. The ligand of the invention has simple preparation, low catalyst consumption and simple and convenient operation, can realize continuous operation, is suitable for large-scale preparation of chiral amine, has an enantiomeric excess value (ee value) of the product of more than 75 percent, and can meet the requirement of being used as a pesticide intermediate. The invention obtains better result for the synthesis of the metolachlor intermediate and has good industrial practicability.

Description

Asymmetric imine hydrogenation method based on chiral monodentate phosphine ligand derived from D-mannitol
Technical Field
The invention belongs to the field of organic synthesis, and particularly relates to a method for asymmetrically hydrogenating imine based on a chiral monodentate phosphine ligand derived from D-mannitol, which is suitable for producing herbicide metolachlor intermediate and metalaxyl-M intermediate.
Background
In asymmetric synthesis reactions, asymmetric catalysis is one of the most efficient and economically valuable methods for obtaining chiral compounds. Chiral amine compounds are important organic synthetic intermediates useful in the preparation of a variety of natural and unnatural compounds having biological activity. In recent years, the preparation of chiral amine compounds by asymmetric catalytic Hydrogenation of imines has been very successful [ (a) H. -U.Blaser, F.Spinder in Handbook of Homogeneous Hydrogenation (eds.: J.G.de Vries, C.J.Elsevier), Wiley-VCH, Weinheim,2007, pp.1193; (b) claver, e.fernandez in Morden Reduction Methods (eds.: p.anderson, i.munsell), Wiley-VCH, Weinheim,2008, pp.237; (c) U.Blaser, F.Spinder in Comprehensive asymmetry catalysis catalysts (eds.: E.Jacobsen, A.Pfaltz, H.Yamamoto), Springer, Berlin,1999, pp.247 ], but the catalytic systems have the problems of low reaction activity, narrow substrate range, harsh reaction conditions and the like, and particularly, for the synthetic route of obtaining the refined metolachlor through asymmetric catalysis, a plurality of different attempts are made by organic chemists at home and abroad to design and synthesize a plurality of asymmetric catalytic catalysts. The preparation of s-metolachlor intermediates by asymmetric hydrogenation of (2-methyl-6-ethylaniline) -imines was found to be a viable and efficient route.
In 1975, Levi et al reported a hydrogenation process for imines, but the enantiomeric excess (ee value) was only 22% (Levi A., Modena G., Scorano G.J.chem.Soc.Commun.1975,1, 6-7). In 1999, Hans-PeterJalett et al catalyzed asymmetric hydrogenation with ferrocene bisphosphine ligand increased its ee value to 76% (Jalett H.P., Spindler F., Hanreich R.G.US5886225[ P ],1999) and achieved industrialization. The method is characterized in that { (R) -1- [ (S) -2-diphenylphosphine cyclopentadienyl iron group ] } ethyl-bis- (3, 5-dimethylphenyl) phosphine is used as a ligand and forms a catalyst precursor with an iridium complex in situ, and the asymmetric hydrogenation of 2-methyl-6-ethyl-N-methyleneaniline is catalyzed in the presence of acid and tetrabutylammonium iodide at 50 ℃ and 80 atmospheres of hydrogen pressure to obtain chiral amine with the highest ee of 76%. However, the synthesis of the ligand used in this reaction is difficult, and the hydrogenation system requires a large amount of acid and requires high equipment. Therefore, the development of the catalyst for preparing the chiral amine with high activity, high stereoselectivity and low cost has very important significance.
Disclosure of Invention
The invention aims to provide a method for asymmetrically hydrogenating imine based on a chiral monodentate phosphine ligand derived from D-mannitol, which solves the technical problems that: the chiral monodentate phosphine ligand derived from the D-mannitol has simple synthesis, low cost and is suitable for kilogram-level production, the iridium/D-mannitol-derived chiral monodentate phosphine ligand system has high catalytic activity and high enantioselectivity, and the enantiomeric excess value (ee value) of the product reaches over 75 percent
In order to achieve the purpose, the technical scheme of the invention is as follows:
a method for asymmetrically hydrogenating imine based on a chiral monodentate phosphine ligand derived from D-mannitol adopts a chiral catalyst Ir-L to asymmetrically hydrogenate imine to prepare chiral amine; the chiral catalyst Ir-L is generated by in-situ coordination of an iridium-cyclooctadiene complex and a chiral monodentate phosphine ligand derived from D-mannitol in a solvent.
A method for asymmetric hydrogenation of imine based on a chiral monodentate phosphine ligand derived from D-mannitol comprises the following steps:
under the protection of nitrogen, dissolving an iridium-cyclooctadiene complex and a chiral monodentate phosphine ligand derived from D-mannitol in a solvent, stirring for 10 minutes at room temperature, adding a substrate imine dissolved in the solvent, placing the substrate imine in a high-pressure reaction kettle, performing hydrogen replacement for 3 times, introducing hydrogen to 20-100bar, reacting for 1-24 hours at 20-100 ℃, slowly releasing the hydrogen, removing the solvent, and separating by using a silica gel column to obtain the product chiral amine.
The solvent is dichloromethane, 1, 2-dichloroethane or toluene;
the structural formula of the substrate imine is as follows:
Figure BDA0001898017910000031
wherein R is1Is C1~C10Alkyl radical, C3~C12Cycloalkyl radicals, or containing one or two of N, S, O, PC of the above functional group1~C10Alkyl, or C containing one or more functional groups of N, S, O, P3~C10A cycloalkyl group; or aryl or the like C6-C30Aromatic groups with or without functional groups such as N, S, O, P; or an ester group.
R2Is H, C1-C40Alkyl or aryl within;
ar is phenyl, 2-substituted, 3-substituted, 4-substituted, 2, 6-disubstituted, 2,4, 6-trisubstituted aryl C6-C30Aromatic groups with or without N, S, O, P functional groups.
In order to achieve the purpose, the technical scheme of the invention is as follows:
Figure BDA0001898017910000032
the imines and the chiral amines produced according to the invention have the following structures:
Figure BDA0001898017910000033
wherein R is1Is C1~C10Alkyl radical, C3~C12Cycloalkyl, or C containing one or more functional groups of N, S, O, P1~C10Alkyl, or C containing one or more functional groups of N, S, O, P3~C10A cycloalkyl group; or aryl or the like C6-C30Aromatic groups with or without functional groups such as N, S, O, P; or an ester group R2Is H, C1-C40Alkyl or aryl within;
ar is phenyl, 2-substituted, 3-substituted, 4-substituted, 2, 6-disubstituted, 2,4, 6-trisubstituted aryl C6-C30Aromatic groups with or without N, S, O, P functional groups.
The structural general formula of the chiral monodentate phosphine ligand derived from D-mannitol is as follows:
Figure BDA0001898017910000041
wherein: r is aromatic hydrocarbon or C1-C10An aliphatic group;
the iridium-cyclooctadiene complex is: [ Ir (COD) Cl]2、Ir(COD)2BF4Or Ir (COD)2BARF。
The iridium concentration in the reaction system is 0.0001-0.01mol/l, and the molar ratio of the ligand to the iridium is 1-5: 1.
the molar ratio of the imine substrate to the catalyst is 100-10000: 1.
the invention has the beneficial effects that: compared with other methods for synthesizing chiral amine, the method for synthesizing chiral monodentate phosphine ligand derived from D-mannitol for imine reduction hydrogenation is simple in synthesis, low in price and suitable for kilogram-level production, an iridium/D-mannitol-derived chiral monodentate phosphine ligand system is high in catalytic activity and enantioselectivity, the enantiomeric excess value (ee value) of a product reaches over 75%, the reaction operation is simple, the condition is mild, the atom economy is high, and the method is suitable for industrial production.
Detailed Description
The following examples further illustrate the invention but are not intended to limit the invention thereto. NMR was measured by Bruker NMR and High Performance Liquid Chromatography (HPLC) was measured by Agilent1100 series HPLC. GC analysis conditions were as follows: SE-54, injection port temperature: 250 degrees, detector temperature: initial temperature 50 ℃ for 2 minutes, then 10 ℃ per minute to 250 ℃ and then 5 minutes.
Example 1
Figure BDA0001898017910000051
Under the protection of nitrogen gas, [ Ir (COD) Cl]2(0.0025mmol,0.5 mol%), D-mannitol-derived chiral monodentate phosphine ligand A (shown in the above formula) (0.0055mmol,1.1 mol%) was dissolved in dichloromethane (1.0mL), stirred at room temperature for 10 minutes, a solution of the substrate (E) -2, 6-dimethyl-N- (1-phenylethylidene) aniline (0.5mmol) in dichloromethane (1.0mL) was added, the mixture was placed in an autoclave, replaced with hydrogen gas for 3 times, and then hydrogen gas was introduced to 20 atmospheres, and reacted at room temperature for 24 hours. Slowly releasing hydrogen, removing solvent, and separating by using silica gel column to obtain the product 2, 6-dimethyl-N- (1-phenylethyl) aniline.
The product was analyzed and the NMR and HPLC data are as follows:
98%yield.76%ee(chiralcel OJ-H,n-hexane/i-PrOH=90/10,1.0mL/min,254nm,40℃):tR(major)=4.9min,tR(minor)=5.4min.[α]D25=-158(c=1.42inCHCl3).1H NMR(400MHz,CDCl3):δ=1.54(d,J=6.8Hz,3H),2.19(s,6H),3.22(br,1H),4.34(q,J=6.8Hz,1H),6.81(t,J=7.2Hz,1H),6.97(d,J=7.2Hz,2H),7.25-7.27(m,1H),7.31-7.32(m,4H);13C NMR(100MHz,CDCl3):δ=19.1,22.9,57.0,121.8,121.9,126.3,126.4,127.1,127.2,128.6,128.7,129.0,129.1,129.6,145.2,145.5。
example 2
The reaction conditions in example 1 were changed from D-mannitol-derived chiral monodentate phosphine ligand to B, and the reaction was performed as in example 1 to give 2, 6-dimethyl-N- (1-phenylethyl) aniline in a yield of 98% and an enantioselectivity of 50% ee.
Ligand B has the following structure:
Figure BDA0001898017910000061
example 3
The reaction conditions in example 1 were changed to C for the chiral monodentate phosphine ligand derived from D-mannitol, and the reaction was performed as in example 1 to give 2, 6-dimethyl-N- (1-phenylethyl) aniline in a yield of 98% and an enantioselectivity of 60% ee.
Ligand C has the structure:
Figure BDA0001898017910000062
example 4
The reaction conditions in example 1 were changed from D-mannitol-derived chiral monodentate phosphine ligand to D, and the reaction was performed as in example 1 to give 2, 6-dimethyl-N- (1-phenylethyl) aniline in a yield of 70% and an enantioselectivity of 60% ee.
Ligand D has the structure:
Figure BDA0001898017910000071
example 5
The reaction conditions in example 1 were changed from D-mannitol-derived chiral monodentate phosphine ligand to E, and the reaction was performed as in example 1 to give 2, 6-dimethyl-N- (1-phenylethyl) aniline in 58% yield and with an enantioselectivity of 30% ee.
Ligand E has the structure:
Figure BDA0001898017910000072
example 6
The reaction conditions H in example 1 were2The pressure was changed to 20 atmospheres, and the remainder was the same as in example 1, giving 2, 6-dimethyl-N- (1-phenylethyl) aniline in 90% yield and 80% ee enantioselectivity.
Example 7
The substrate to catalyst ratio in example 1 was changed to 1000S/C, i.e.: [ Ir (COD) Cl]2(0.00025mmol,0.05 mol%) and D-mannitol-derived chiral monodentate phosphine ligand (0.00055mmol,0.11 mol%) reacted to give the product 2, 6-dimethyl-N- (1-phenylethyl) aniline with an enantioselectivity of 74% ee.
Example 8
The substrate to catalyst ratio in example 1 was changed to S/C10000, i.e.: [ Ir (COD) Cl]2(0.000025mmol,0.005 mol%), D-mannitol-derived chiral monodentate phosphine ligand (0.000055mmol,0.011 mol%), reaction conditions H2A pressure ofThe same as in example 1 except that the reaction was carried out at 80 atm, 100 ℃ and 36 hours, the enantioselectivity of the product 2, 6-dimethyl-N- (1-phenylethyl) aniline was 73% ee.
Example 9
The substrate in the example 1 is changed into p-nitroacetophenone, and the reaction is carried out in the same way as the example 1 to obtain the product 2, 6-dimethyl-N- (1- (4-nitrophenyl) ethylideneaniline.
The product was analyzed and the NMR and HPLC data are as follows:
99%yield.77%ee(chiralpak AD-H,n-hexane/i-PrOH=99/1,1.0mL/min,254nm,40℃):tR(major)=5.4min,tR(minor)=7.5min.[α]D 25=-233(c=1.90inCHCl3).1HNMR(400MHz,CDCl3):δ=1.57(d,J=6.8Hz,3H),2.16(s,6H),3.13(br,1H),4.40(q,J=6.8Hz,1H),6.81(t,J=7.2Hz,1H),6.96(d,J=7.2Hz,2H),7.45(d,J=8.8Hz,2H),8.15(d,J=8.8Hz,2H);13C NMR(100MHz,CDCl3):δ=19.0,22.9,56.5,122.1,123.6,127.1,129.1,129.3,144.4,146.9,152.9。
example 10
The substrate in example 1 was changed to 3-nitroacetophenone, and the reaction was carried out in the same manner as in example 1 to give 2, 6-dimethyl-N- (1- (3-nitrophenyl) ethylaniline).
The product was analyzed and the NMR and HPLC data are as follows:
98%yield.78%ee(chiralpak AD-H,n-hexane/i-PrOH=99/1,1.0mL/min,254nm,40℃):tR(minor)=10.3min,tR(major)=10.9min.[α]D 25=-141(c=1.88inCHCl3).1H NMR(400MHz,CDCl3):δ=1.58(d,J=6.8Hz,3H),2.19(s,6H),3.20(br,1H),4.43(q,J=6.8Hz,1H),6.82(t,J=7.6Hz,1H),6.97(d,J=7.6Hz,2H),7.45(t,J=7.6Hz,1H),7.62(d,J=7.6Hz,1H),8.10(d,J=7.6Hz,1H),8.24(s,1H);13C NMR(100MHz,CDCl3):δ=19.0,23.0,56.3,121.0,122.0,122.2,129.1,129.3,129.4,132.7,144.3,147.5,148.3。
example 11
The substrate in the example 1 is changed into butanone, and the reaction is carried out in the same way as the example 1 to obtain the product N-isobutyl-2, 6-dimethylaniline.
The product was analyzed and the GC and NMR data are shown below:
94%yield.74%ee(chiralβ-DEX 120column(0.25mm x 30m),columntemp.:90℃,carrier gas:N2):tR(major)=20.1min,tR(minor)=20.8min.[α]D 25=-41(c=0.96inCHCl3).1HNMR(400MHz,CDCl3):δ=0.98(t,J=7.2Hz,3H),1.07(d,J=6.4Hz,3H),1.37-1.44(m,1H),1.58-1.64(m,1H),2.28(s,6H),2.84(br,1H),3.21(q,J=6.8Hz,1H),6.80(t,J=7.2Hz,1H),6.99(d,J=7.2Hz,2H);13C NMR(100MHz,CDCl3):δ=7.1,15.3,17.1,27.2,50.1,117.4,125.1,141.5。
example 12
The substrate in the example 1 is changed into methoxy acetone, and the reaction is carried out in the same way as the example 1 to obtain the product N- (1-methoxy-2-propyl) -2, 6-dimethylaniline.
The product was analyzed and the GC and NMR data are shown below:
95%yield.78%ee(chiralβ-DEX 120column,column temp.:85℃,carriergas:N2):tR(major)=69.8min,tR(minor)=71.4min.[α]D 25=9.5(c=1.31in CHCl3).1HNMR(400MHz,CDCl3):δ=1.20(d,J=6.0Hz,3H),2.30(s,6H),3.35-3.80(m,7H),6.82(t,J=7.2Hz,1H),6.99(d,J=7.2Hz,2H);13C NMR(100MHz,CDCl3):δ=18.6,18.7,52.4,59.0,76.3,121.5,128.8,129.4,145.0。
example 13
The substrate in the example 1 is changed into acetone methyl ester, and the reaction is carried out in the same way as the example 1 to obtain the product 2- (2, 6-dimethylphenylamino) methyl propionate.
The product was analyzed and the NMR and HPLC data are as follows:
96%yield.77%ee(chiralcel OD-H,n-hexane/i-PrOH=99/1,1.0mL/min,254nm,40℃):tR(minor)=6.9min,tR(major)=7.7min.[α]D 25=-16(c=1.33inCHCl3).1HNMR(400MHz,CDCl3):δ=1.38(d,J=7.2Hz,3H),2.31(s,6H),3.68(s,3H),4.00(q,J=7.2Hz,1H),6.81(t,J=7.6Hz,1H),6.97(d,J=7.6Hz,2H)。
example 14
The substrate in the example 1 is changed into propiophenone, and the rest is reacted with the substrate in the example 1 to obtain the product 2, 6-dimethyl-N- (1-phenylpropyl) aniline.
The product was analyzed and the NMR and HPLC data are as follows:
97%yield.72%ee(chiralcel OJ-H,n-hexane/i-PrOH=90/10,1.0mL/min,254nm,40℃):tR(major)=4.4min,tR(minor)=4.8min.[α]D 25=-116(c=1.79inCHCl3).1HNMR(400MHz,CDCl3):δ=0.91(d,J=7.2Hz,3H),1.87-1.92(m,1H),2.02-2.05(m,1H),2.18(s,6H),3.30(br,1H),4.07(m,1H),6.78(t,J=7.2Hz,1H),6.94(d,J=7.2Hz,2H),7.20-7.31(m,5H);13CNMR(100MHz,CDCl3):δ=11.3,19.1,29.8,63.5,121.4,126.3,126.8,127.0,128.4,128.9,129.1,143.9,145.0。
example 15
Figure BDA0001898017910000101
Under the protection of nitrogen gas, [ Ir (COD) Cl]2(0.00125mmol,0.0005 mol%), D-mannitol-derived chiral monodentate phosphine ligand (0.00275mmol,0.0011 mol%) and n-Bu4NI (0.0125mmol,0.005 mol%) was dissolved in 1, 2-dichloroethane (10mL), stirred at room temperature for 10 minutes, a solution of the substrate 2-ethyl-N- (1-methoxy-2-propylene) -6-methylaniline (0.25mol) in 1, 2-dichloroethane (10mL) was added, the mixture was placed in an autoclave, replaced with hydrogen for 3 times, and then hydrogen was introduced to 80 atmospheres and reacted at 100 ℃ for 18 hours. Slowly releasing hydrogen, removing solvent, and separating with silica gel column to obtain the product (S) -2-ethyl-N- (1-methoxy-2-propyl) -6-methylaniline.
The product was analyzed and the NMR and HPLC data are as follows:
95%yield.75%ee(chiralcel OD-H,n-hexane/i-PrOH=99/1,1.0mL/min,254nm,40℃):tR(minor)=4.4min,tR(major)=4.8min.[α]D 25=8.8(c=1.0in CHCl3).1HNMR(400MHz,CDCl3):δ=1.18(d,J=5.6Hz,3H),1.23(t,J=7.6Hz,3H),2.29(s,3H),2.65(q,J=7.6Hz,2H),3.34-3.38(m,6H),6.87(t,J=7.6Hz,1H),7.00(dd,J=7.6,15.2Hz,2H)。

Claims (7)

1. a method for asymmetrically hydrogenating imine based on a chiral monodentate phosphine ligand derived from D-mannitol is characterized by comprising the following steps: the method adopts a chiral catalyst Ir-L and adopts imine asymmetric hydrogenation to prepare chiral amine; the chiral catalyst Ir-L is generated by in-situ coordination of an iridium-cyclooctadiene complex and a chiral monodentate phosphine ligand derived from D-mannitol.
2. The asymmetric imine hydrogenation process based on a chiral monodentate phosphine ligand derived from D-mannitol according to claim 1, wherein: the method specifically comprises the following steps:
under the protection of nitrogen, dissolving an iridium-cyclooctadiene complex and a chiral monodentate phosphine ligand derived from D-mannitol in a solvent, stirring for 10 minutes at room temperature, adding a substrate imine dissolved in the solvent, placing the substrate imine in a high-pressure reaction kettle, performing hydrogen replacement for 3 times, introducing hydrogen to 20-100bar, reacting for 1-24 hours at 20-100 ℃, slowly releasing the hydrogen, removing the solvent, and separating by using a silica gel column to obtain a product chiral amine;
the solvent is dichloromethane, 1, 2-dichloroethane or toluene.
3. The asymmetric imine hydrogenation process based on a chiral monodentate phosphine ligand derived from D-mannitol according to claim 1 or 2, characterized in that; the substrate imine and the prepared chiral amine respectively have the following structures:
Figure FDA0001898017900000011
in the formula:
R1is C1~C10Alkyl radical, C3~C12Cycloalkyl, or C containing one or more functional groups of N, S, O, P1~C10Alkyl, or C containing one or more functional groups of N, S, O, P3~C10A cycloalkyl group; or aryl or the like C6~C30Aromatic groups with or without N, S, O, P functional groups, or ester groups;
R2is H, C1~C40Alkyl or aryl within;
ar is phenyl, 2-substituted, 3-substituted, 4-substituted, 2, 6-disubstituted, 2,4, 6-trisubstituted aryl; c6~C30Aromatic groups with or without N, S, O, P functional groups.
4. The asymmetric imine hydrogenation process based on a chiral monodentate phosphine ligand derived from D-mannitol according to claim 1 or 2, characterized in that: the structural general formula of the D-mannitol derived chiral monodentate phosphine ligand is as follows:
Figure FDA0001898017900000021
wherein R is aromatic hydrocarbon or C1~C10An aliphatic group.
5. The asymmetric imine hydrogenation process based on a chiral monodentate phosphine ligand derived from D-mannitol according to claim 1 or 2, characterized in that: the iridium-cyclooctadiene complex is: [ Ir (COD) Cl]2、Ir(COD)2BF4Or Ir (COD)2BARF。
6. The asymmetric imine hydrogenation process based on a chiral monodentate phosphine ligand derived from D-mannitol according to claim 2, characterized in that: the iridium concentration is 0.0001-0.01mol/L, and the molar ratio of the D-mannitol-derived chiral monodentate phosphine ligand to iridium is 1-5: 1.
7. the asymmetric imine hydrogenation process based on a chiral monodentate phosphine ligand derived from D-mannitol according to claim 2, characterized in that: the molar ratio of the imine substrate to the catalyst Ir-L is 100-10000: 1.
CN201811500419.8A 2018-12-10 2018-12-10 Asymmetric imine hydrogenation method based on chiral monodentate phosphine ligand derived from D-mannitol Pending CN111285774A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811500419.8A CN111285774A (en) 2018-12-10 2018-12-10 Asymmetric imine hydrogenation method based on chiral monodentate phosphine ligand derived from D-mannitol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811500419.8A CN111285774A (en) 2018-12-10 2018-12-10 Asymmetric imine hydrogenation method based on chiral monodentate phosphine ligand derived from D-mannitol

Publications (1)

Publication Number Publication Date
CN111285774A true CN111285774A (en) 2020-06-16

Family

ID=71019004

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811500419.8A Pending CN111285774A (en) 2018-12-10 2018-12-10 Asymmetric imine hydrogenation method based on chiral monodentate phosphine ligand derived from D-mannitol

Country Status (1)

Country Link
CN (1) CN111285774A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1579627A (en) * 2003-08-05 2005-02-16 中国科学院大连化学物理研究所 Chiral ligand metal complex catalyst system, and its preparation method and use
CN103570484A (en) * 2012-08-07 2014-02-12 中国科学院大连化学物理研究所 Asymmetric hydrogenation synthetic method of chiral aromatic amine compound with high steric hindrance

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1579627A (en) * 2003-08-05 2005-02-16 中国科学院大连化学物理研究所 Chiral ligand metal complex catalyst system, and its preparation method and use
CN103570484A (en) * 2012-08-07 2014-02-12 中国科学院大连化学物理研究所 Asymmetric hydrogenation synthetic method of chiral aromatic amine compound with high steric hindrance

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NATASA MRSIC等: "Iridium/Monodentate Phosphoramidite Catalyzed Asymmetric Hydrogenation of N-Aryl Imines", 《J. AM. CHEM. SOC.》 *
SERGEY E. LYUBIMOV等: "Iridium-catalyzed asymmetric hydrogenation of imines in supercritical carbon dioxide using phosphite-type ligands", 《TETRAHEDRON LETTERS》 *

Similar Documents

Publication Publication Date Title
CN110551037B (en) Method for catalyzing asymmetric hydrogenation of imine by iridium/chiral diphosphine system
CN102006930B (en) Hydrogenation of imines
EP1276745B1 (en) Ruthenium-diphosphine complexes and their use as catalysts
CN110548546A (en) Method for catalyzing asymmetric hydrogenation of imine by iridium/linear phosphine-phosphoramidite system
CN103570484A (en) Asymmetric hydrogenation synthetic method of chiral aromatic amine compound with high steric hindrance
CN112824422B (en) Chiral ferrocene-indole diphosphine ligand as well as preparation method and application thereof
CN109422603A (en) A kind of method of iridium catalysis asymmetric hydrogenation imines synthesis of chiral amine compounds
CN110551035A (en) Iridium-catalyzed asymmetric reductive amination method for ketone
CN110551036B (en) Iridium/chiral phosphite ester-pyridine catalyzed imine asymmetric hydrogenation method
CN111285775B (en) Method for applying fructose-derived pyridine alcohol chiral ligand to asymmetric reductive amination of ketone
CN111285774A (en) Asymmetric imine hydrogenation method based on chiral monodentate phosphine ligand derived from D-mannitol
CN111285773A (en) Method for preparing chiral amine based on glucose-derived monodentate phosphite ligand asymmetric hydrogenation
CN111285770B (en) Asymmetric reductive amination method based on fructose-derived chiral monodentate phosphite ligand ketone
CN110551034B (en) Asymmetric reductive amination method of ketone
CN110551033B (en) Method for preparing chiral amine through asymmetric reductive amination of ketone
CN110551032B (en) Asymmetric reductive amination method for catalyzing ketone by iridium chiral phosphine-aminophosphine ligand system
CN109422602A (en) A kind of method of asymmetric hydrogenation imines preparation Chiral Amine
JP5042438B2 (en) Process for producing β-aminoalcohols having a syn configuration
CN114085157A (en) Preparation method for preparing s-metolachlor intermediate by asymmetric hydrogenation
US20030119664A1 (en) Chiral monophosphorus compounds
CN114539319B (en) Chiral phosphine-dicyclophosphoramidite ligand and preparation method and application thereof
WO2006094800A2 (en) Cascade reaction process
CN110494412A (en) Chiral metal complex
CN111269141B (en) Method for synthesizing imine by catalyzing alcohol-amine with NNN cobalt complex
US8822680B2 (en) Paracyclophane-based ligands, their preparation and use in catalysis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200616